Clinical Trial Update: Cimzia Treatment in Rheumatoid Arthritis: Randomizing to Stop Versus Continue Disease-modifying Anti-rheumatic Drug(s)

View source ↗

Summary

This clinical trial update describes a randomized study evaluating stopping versus continuing disease-modifying anti-rheumatic drug therapy in patients with rhe…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• CIMZIA (CERTOLIZUMAB PEGOL)

Snippet

Sponsor: Pope Research Corporation | Conditions: Rheumatoid Arthritis | Status: UNKNOWN